ACCURAY INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.185 USD | +0.23% |
|
+2.10% | -22.79% |
Presenter SpeechElizabeth Kennard (Executives)Welcome to Accuray's Investor Briefing meeting a...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.
Calendar
2024-04-30
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.19
USD
Average target price
8.75
USD
Spread / Average Target
+299.54%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.79% | 217M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- ARAY Stock
- News Accuray Incorporated
- Transcript : Accuray Incorporated - Analyst/Investor Day
